IDEXX Laboratories, Inc.

IX1.F·Frankfurt·Healthcare
Compare
616.20+22.20 (+3.88%)today
As of Nov 5, 8:01 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close594.00
Open616.20
Day range—
52-week range434.30665.80
Off day high0.00%
Off 52-week high−7.45%
Volume200
Avg. volume (3M)5.00
Market cap48.55B
EPS (TTM)12.90
Forward P/E65.69
P/E ratio (TTM)47.77
Dividend yield—
Beta (5Y)1.54
Shares outstanding78.79M
Short interest—
Earnings dateNov 2, 2026 (est.)
Analyst target—
Profit margin25.36%

Against its peers

Compare in full ›
IX1.F LH 4544.T ICLR EYWN.F TMO
Market cap 48.55B 29.86B 217.00B 15.22B 11.46B 261.64B
P/E (TTM) 47.8 30.1 23.5 81.2 25.0 37.2
Forward P/E 65.7 18.8 39.3 17.5 — 25.4
Price/book 29.2 3.4 1.6 1.7 2.7 4.8
Dividend yield — 0.78% 3.22% — 1.09% 0.27%
1-year change −4.00% +49.12% −0.56% +26.94% −12.44% +24.77%
Today +3.88% +3.92% +3.51% −0.32% +3.23% +1.12%

The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.

Latest news

All IX1.F news ›
Seeking Alpha·Positive

IDEXX Laboratories: Q3 Results Confirm They Are Best-In-Class

IDEXX Laboratories has best-in-class diagnostics, high recurring revenue, and a robust innovation pipeline. Find out why IDXX stock is a buy. - IDEXX Laboratories delivered strong Q3 results, beating expectations with 9.86% organic revenue…

Seeking Alpha·Positive

IDEXX Laboratories surges 22% on Q3 beat, raised outlook

(IDXX:NASDAQ) Seeking Alpha SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. aluxum/E+ via Getty Images Shares of IDEXX Laboratories (IDXX), a developer…

24/7 Wall St.·

IDEXX Laboratories Q3 2026: EPS Beats by 8%, Guidance Raised

As seen on the 24/7 Wall St. homepage on November 2, 2026. IDEXX Laboratories posted Q3 2026 GAAP EPS of $4.01, beating expectations and extending its streak of beating consensus EPS to seven consecutive quarters. CAG Diagnostics recurring…

From the 4Search news index, newest first.

In the news

60mentions in 30 days
60with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 60 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance